GlassScriptPhysician profile
Michael J Rosen
NPI 1629098322
$13,437.01
in general payments reported to CMS, 2019-2025
19 companies · $592 in 2025
The $592 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $618 · 2020: $1,374 · 2021: $400 · 2022: $2,267 · 2023: $3,998 · 2024: $4,190 · 2025: $592.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,979 · Food and Beverage: $3,300 · Consulting Fee: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,979.16 |
| Food and Beverage | $3,299.85 |
| Consulting Fee | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $6,818.41 | 2022-2025 | Progrip, Signia, Ligasure |
| Intuitive Surgical, INC. | $1,453.54 | 2022-2023 | Da Vinci Surgical System |
| Davol INC. | $1,423.78 | 2019-2025 | Phasix Mesh, Echo Ps Positioning System |
| Pacira Pharmaceuticals Incorporated | $1,152.88 | 2020 | |
| Covidien LP | $508.01 | 2019-2020 | |
| Boston Scientific Corporation | $418.89 | 2023-2024 | Spyglass Discover |
| Tela Bio, INC. | $326.31 | 2021-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| W. L. Gore & Associates, INC. | $255.84 | 2019-2023 | Gore Synecor Biomaterial |
| Baxter Healthcare | $181.49 | 2022-2024 | Perclot |
| Kerecis Limited | $162.72 | 2022 | |
| Innovation Technologies INC | $150.99 | 2025 | Irrisept |
| Integra Lifesciences Corporation | $142.37 | 2022-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| C. R. Bard, INC. & Subsidiaries | $132.60 | 2022 | |
| Heron Therapeutics, INC. | $117.27 | 2021 | |
| Conmed Corporation | $113.95 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $47.03 | 2024 | Phasix Mesh |
| Solventum Corporation | $30.93 | 2024 | V.A.C.Ulta, Prevena |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Rosen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.